Late-onset NPM1 mutation in a MYC-amplified relapsed / refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib.

Authors :: Jaramillo S
Scherer M
Szu-Tu C
Beneyto-Calabuig S
Müller-Tidow C
Schlenk RF
Hundemer M
Velten L
Pabst C
Source :: Haematologica [Haematologica] 2024 May 30. Date of Electronic Publication: 2024 May 30.
Publication Year :: 2024
Publisher :: Ahead of Print
Abstract: Not available.

Full Text Access

Tools